Efficacy and Safety of Thulium Laser Vaporization of the Prostate: A Transurethral Procedure for Benign Prostatic Hyperplasia
LUTS: Lower Urinary Tract Symptoms · 2025
DOI: 10.1111/luts.70012 ↗Kurz gefasst
Fachartikel in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, 2025. Verfasst von Daisuke Gotoh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Kashihara, Japan. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Thulium, Laser Therapy, Transurethral Resection of Prostate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objectives
To explore the efficacy and safety of thulium laser vaporization of the prostate (ThuVAP) for benign prostatic hyperplasia (BPH) at Nara Medical University from 2022 to 2024.
Methods
Patients with BPH who underwent ThuVAP at the Department of Urology, Nara Medical University, between January 01, 2022 and April 30, 2024, were enrolled. Patient background, presurgical pressure flow study results, treatment efficacy, and safety were retrospectively evaluated.
Results
The study included 32 patients; the median age was 74.5 years at surgery. The total International Prostate Symptom Score and quality of life were significantly lower at 4 weeks after surgery than at baseline. They continued to decrease at 12 and 24 weeks. The maximum flow rate was significantly higher at 4 weeks after surgery than at baseline; it continued to increase for 12 and 24 weeks. The postvoid residual (PVR) was significantly lower at 4 weeks after surgery than at baseline and continued to decrease at 12 and 24 weeks. Intravesical prostatic protrusion and prostate volume were positively correlated with the surgery and laser usage times. Two patients experienced temporary urinary retention, and two underwent transurethral electrocoagulation for postoperative bleeding.
Conclusions
Our data confirm ThuVAP as an effective and safe treatment for BPH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nara Medical University, Kashihara, Japan.
- Department of Urology, Nara Prefecture General Medical Center, Nara, Japan.
ORCID-Profile: Daisuke Gotoh, Makito Miyake
Zitieren
APA
Gotoh, D., Torimoto, K., Tachibana, A., Nishimura, N., Tomizawa, M., Onishi, K., Morizawa, Y., Hori, S., Nakai, Y., Miyake, M., & Fujimoto, K. (2025). Efficacy and Safety of Thulium Laser Vaporization of the Prostate: A Transurethral Procedure for Benign Prostatic Hyperplasia. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.70012
Vancouver
Gotoh D, Torimoto K, Tachibana A, Nishimura N, Tomizawa M, Onishi K, et al. Efficacy and Safety of Thulium Laser Vaporization of the Prostate: A Transurethral Procedure for Benign Prostatic Hyperplasia. LUTS: Lower Urinary Tract Symptoms. 2025. doi:10.1111/luts.70012
BibTeX
@article{Gotoh2025,
author = {Gotoh, Daisuke and Torimoto, Kazumasa and Tachibana, Akira and Nishimura, Nobutaka and Tomizawa, Mitsuru and Onishi, Kenta and Morizawa, Yosuke and Hori, Shunta and Nakai, Yasushi and Miyake, Makito and Fujimoto, Kiyohide},
title = {Efficacy and Safety of Thulium Laser Vaporization of the Prostate: A Transurethral Procedure for Benign Prostatic Hyperplasia},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2025},
doi = {10.1111/luts.70012}
}
EUVIMED